Burgard, C.; Khreish, F.; Dahlmanns, L.; Blickle, A.; Bastian, M.B.; Speicher, T.; Maus, S.; Schaefer-Schuler, A.; Bartholomä, M.; Petto, S.;
et al. Analysis of Molecular Imaging Biomarkers Derived from [18F]FDG PET/CT in mCRPC: Whole-Body Total Lesion Glycolysis (TLG) Predicts Overall Survival in Patients Undergoing [225Ac]Ac-PSMA-617-Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy. Cancers 2024, 16, 3532.
https://doi.org/10.3390/cancers16203532
AMA Style
Burgard C, Khreish F, Dahlmanns L, Blickle A, Bastian MB, Speicher T, Maus S, Schaefer-Schuler A, Bartholomä M, Petto S,
et al. Analysis of Molecular Imaging Biomarkers Derived from [18F]FDG PET/CT in mCRPC: Whole-Body Total Lesion Glycolysis (TLG) Predicts Overall Survival in Patients Undergoing [225Ac]Ac-PSMA-617-Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy. Cancers. 2024; 16(20):3532.
https://doi.org/10.3390/cancers16203532
Chicago/Turabian Style
Burgard, Caroline, Fadi Khreish, Lukas Dahlmanns, Arne Blickle, Moritz B. Bastian, Tilman Speicher, Stephan Maus, Andrea Schaefer-Schuler, Mark Bartholomä, Sven Petto,
and et al. 2024. "Analysis of Molecular Imaging Biomarkers Derived from [18F]FDG PET/CT in mCRPC: Whole-Body Total Lesion Glycolysis (TLG) Predicts Overall Survival in Patients Undergoing [225Ac]Ac-PSMA-617-Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy" Cancers 16, no. 20: 3532.
https://doi.org/10.3390/cancers16203532
APA Style
Burgard, C., Khreish, F., Dahlmanns, L., Blickle, A., Bastian, M. B., Speicher, T., Maus, S., Schaefer-Schuler, A., Bartholomä, M., Petto, S., Ezziddin, S., & Rosar, F.
(2024). Analysis of Molecular Imaging Biomarkers Derived from [18F]FDG PET/CT in mCRPC: Whole-Body Total Lesion Glycolysis (TLG) Predicts Overall Survival in Patients Undergoing [225Ac]Ac-PSMA-617-Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy. Cancers, 16(20), 3532.
https://doi.org/10.3390/cancers16203532
